BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Onyx Pharmaceuticals, Inc. 

249 E. Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-266-0000 Fax: 650-266-0100


SEARCH JOBS

View Clinical Trials from BioPharm Insight


About Onyx Pharmaceuticals, Inc.

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com. Onyx Pharmaceuticals is on Twitter. Sign up to follow our Twitter feed @OnyxPharm at http://twitter.com/OnyxPharm.


 Key Statistics


Email:
Ownership: Public

Web Site: Onyx
Employees: 900
Symbol: AMGN
 



Industry
Biotechnology






 Company News
Medtronic (MDT) Initiates Pivotal Studies Of Resolute Onyx (AMGN) Drug-Eluting Stent In United States 3/12/2015 9:22:17 AM
Fate Unknown for Remaining 200 Onyx (AMGN) Employees; Will They Head to Washington State? 3/12/2015 12:58:15 AM
The Reason Why Onyx (AMGN)'s Experiment To Become The Next Genentech (RHHBY) Failed 3/11/2015 2:59:37 PM
Amgen (AMGN) Will Shutter SSF Onyx (AMGN) Site, Lay Off At Least 300 3/10/2015 3:22:34 PM
Why Ex-Onyx (ONXX) CEO And Big Pharma Are Taking On Brain Diseases 2/13/2015 7:39:05 AM
Ex-Onyx Pharmaceuticals, Inc. (ONXX) CEO Leads MA Biotech Startup 12/15/2014 6:06:25 AM
Amgen (AMGN) And Onyx Pharmaceuticals, Inc. (ONXX) Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma 12/8/2014 6:12:14 AM
Amgen (AMGN) And Onyx Pharmaceuticals, Inc. (ONXX) Data At American Society of Clinical Oncology 2014 Highlight Oncology Pipeline And Portfolio 5/28/2014 6:23:06 AM
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX)'s Nexavar Misses Target In Phase 3 Liver Cancer Trial 3/11/2014 6:25:33 AM
Ligand Pharmaceuticals Inc. (LGND) To Receive $1 Million Kyprolis® Commercial Milestone Payment From Onyx Pharmaceuticals, Inc. (ONXX) 2/11/2014 8:48:15 AM
12345678910...